Konferenzschrift | Kongress
Treatment options in ErbB2 (HER2)-Positive breast cancer : Symposium, November 2- 3, 2007, Munich ; 3 Tabellen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783805585958
- Maße
-
30 cm
- Umfang
-
23 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Literaturangaben
- Erschienen in
-
Breast care ; Vol. 3, Suppl. 1
- Schlagwort
-
Brustkrebs
Therapie
Krebs
Onkologie
Mamma
- Ereignis
-
Veröffentlichung
- (wo)
-
Basel, Freiburg, Br., Paris, London, New York, NY, Bangalore, Bangkok, Shanghai, Singapore, Tokyo, Sydney
- (wer)
-
Karger
- (wann)
-
2008
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Jackisch, Christian
- Karger
Entstanden
- 2008
Ähnliche Objekte (12)
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Systemic therapy for women with ErbB2-positive breast cancer : new options, new challenges ; symposium, October 23 - 24, 2009, Munich ; 2 tables
EGFR Expression in HER2-Driven Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Die Interaktion von ErbB2/Her2 mit Hitzeschockproteinen in Mammakarzinomzellen
Immunotherapy: new options in breast cancer treatment
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Systemic therapy for women with ErbB2-positive breast cancer : new options, new challenges ; symposium, October 23 - 24, 2009, Munich ; 2 tables
EGFR Expression in HER2-Driven Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Die Interaktion von ErbB2/Her2 mit Hitzeschockproteinen in Mammakarzinomzellen
Immunotherapy: new options in breast cancer treatment
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Systemic therapy for women with ErbB2-positive breast cancer : new options, new challenges ; symposium, October 23 - 24, 2009, Munich ; 2 tables
EGFR Expression in HER2-Driven Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Die Interaktion von ErbB2/Her2 mit Hitzeschockproteinen in Mammakarzinomzellen
Immunotherapy: new options in breast cancer treatment
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells